Status:
RECRUITING
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
Lead Sponsor:
Emory University
Collaborating Sponsors:
National Institute of Nursing Research (NINR)
Conditions:
Human Papilloma Virus
Human Papilloma Virus Vaccine
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
People living with HIV (PLWH) are 28 times more likely to be diagnosed with Human Papillomavirus (HPV) - associated anal cancer than the general population. The HPV vaccine is an effective and safe ap...
Detailed Description
People living with HIV (PLWH) are 28 times more likely to be diagnosed with HPV- associated anal cancer than the general population. The HPV vaccine is an effective and safe approach to prevent and re...
Eligibility Criteria
Inclusion Criteria
- HIV positive
- 18-45 years of age
- Can read and speak English
- Capable of providing informed consent
- Has not previously received three series HPV vaccine
- No contraindications to receiving HPV vaccine (i.e. history of anaphylactic allergy to later, an immediate hypersensitivity to yeast, current moderate or severe acute illness, and/or are currently pregnant).
Exclusion Criteria:
- Has contraindications to receiving the HPV vaccine i.e., history of an anaphylactic allergy to latex, an immediate hypersensitivity to yeast, current moderate or severe acute illness, and/or are currently pregnant)
Key Trial Info
Start Date :
May 22 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
365 Patients enrolled
Trial Details
Trial ID
NCT05065840
Start Date
May 22 2023
End Date
June 1 2027
Last Update
April 24 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Albany Rural Model Clinic
Albany, Georgia, United States, 31705
2
AID Atlanta
Atlanta, Georgia, United States, 30309
3
Faebris
Atlanta, Georgia, United States, 30311
4
AHF Lithonia
Lithonia, Georgia, United States, 30058